Global Blood Therapeutics' Acquisition Value Could Be At Least $3 Billion

By: via Benzinga
Global Blood Therapeutics Inc (NASDAQ: GBT) is in the process of developing GBT440 to reduce the severity and frequency of crises and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.